ScienceMed®

Revisão sistemática e meta-análise sobre biópsia do tumor renal: precisão, segurança e impacto na tomada de decisões clínicas

Nefrologia
Imagem de arquivo, ilustrativa — não é do estudo. Túbulos renais em corte transversal, revestidos por epitélio cúbico, ao microscópio óptico. Berkshire Community College Bioscience Image Library · CC0 · Wikimedia Commons

MetanáliseNível 1 · Evidência consolidadaEuropean urology24 jul 20261 citações

Salvar

Resumo original em inglês

O que aconteceu

We performed a systematic review and meta-analysis to evaluate the diagnostic accuracy, safety, and clinical impact of renal tumor biopsy (RTB) in managing renal cell carcinoma.

O que encontraram

MEDLINE, Embase, and Cochrane CENTRAL were systematically searched for studies evaluating diagnostic accuracy, complications, and clinical impact of RTB. Diagnostic performance was synthesized using hierarchical bivariate random-effects models; concordance between biopsy and surgical specimens was assessed using pooled proportions that were estimated using random-effects meta-analysis. Risk of bias was evaluated with QUADAS-2.

Por que isso importa

RTB is safe and high-yield, with excellent sensitivity, high concordance for benign vs malignant and histotype, but only moderate reliability for tumor grade. RTB is therefore an important aid in refining diagnosis in patients with a renal mass and supporting individualized decision-making.

O que ainda não sabemos

Overall, 103 studies were included. The pooled diagnostic yield of RTB was 90%. Summary sensitivity and specificity for malignancy were 99% and 85%, respectively. Concordance between RTB and surgical pathology was high for benign versus malignant (96%) and histological subtype (89%), but moderate for grade (four-tier: 64%; two-tier: 78%). The overall complication rate was low (3%), with negligible (<1%) Clavien-Dindo ≥3 complications and 1% bleeding events (with only two patients requiring embolization). Tumor seeding was reported only in one study with a pooled seeding proportion of 0%. RTB findings was associated with a change in clinical management in 39% of patients and avoidance of active treatment in 28%. Most studies were at high risk of bias, mainly due to patient selection and flow/timing, and were predominantly retrospective.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making

Georges Mjaess, Michele Nicolazzini, Daniele Amparore, Axel Bex, Riccardo Campi, Francesco Cei, Sabrina L Noyes, Chiara Re, Giuseppe Rosiello, Grant D Stewart et al.

Descritores MeSH

  • Clinical Decision-Making
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Reproducibility of Results
  • Humans
  • Neoplasm Grading
  • Predictive Value of Tests
  • Risk Factors
  • Clinical Relevance
  • Biopsy

Veja também

Estudos relacionados